MDACC Study Summary 2007-0447

Study Summary
No. 2007-0447:.......Cancer Prevention......Thuy M. Vu......Surgical Oncology

Study Summary Title



Study Summary Number:	2007-0447

Study Title:	Assessment of Clinical Genetic Services for Hereditary Pancreas Cancer

Physician

New Patient Referral



Name:	Thuy M. Vu	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	Surgical Oncology	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-792-6940 Contact us about clinical trials

General Information



Disease Group:	Cancer Prevention	Supported By:	Huntsman Cancer Institute

Phase of Study:	N/A	Return Visit:	N/A

Treatment Agents:	None	Home Care:	N/A

Treatment Loc:	Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions

Estimated Length of Stay in Houston:	N/A


Description/ Intervention:	The goal of this research study is to learn the best way to provide information about pancreatic cancer and genetics to individuals and families with a history of pancreas cancer. This study will also try to learn how people use the information from their cancer genetics risk assessment to make health decisions.

Study Objectives / Outcomes

This is a descriptive study, and specific hypotheses are not being tested. Here we summarize our objectives and specific aims.

Objective 1: Assess the level of interest in genetic services among families at risk for pancreas cancer.
Specific aim 1: Describe motivators and barriers for seeking genetic services.
Specific aim 2: Identify factors, including demographics, knowledge, anxiety, depression, and risk perception, which may predict interest in genetic services.

Objective 2: Evaluate effect of genetic evaluations for familial pancreas cancer on psychological wellbeing, family communication, and behavioral outcomes.
Specific aim 1: Describe the overall satisfaction with genetic counseling sessions and identify the components of the session participants found most useful.
Specific aim 2: Describe patterns of sharing information from genetics evaluation with family members.
Specific aim 3: Describe uptake of genetic testing, DNA banking, participation in other research trials, and intent to have cancer screening following a genetics evaluation for familial pancreas cancer.

Study Status Information



Study Activation / Registration Date:	02/11/2008

IRB Review and Approval Date:	02/11/2008

Study Type:	Behavioral

Recruitment Status:	Closed

Projected Accrual:	40

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) Participants who have been referred for clinical cancer risk assessment for family history of pancreas cancer.

2) Participants must be 18 years of age or greater, read and speak English.

Exclusion Criteria:

1) Participants who have had prior genetics evaluation for a hereditary cancer syndrome.

Links

Registration Number: Not Applicable Clinical Trial